Evidence for nonvesicular nitric oxide release evoked by nerve activation.
about
Botulinum toxin for gastrointestinal disorders: therapy and mechanisms.Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury.Substance P is essential for maintaining gut muscle contractility: a novel role for coneurotransmission revealed by botulinum toxin.Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons.Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons.
P2860
Evidence for nonvesicular nitric oxide release evoked by nerve activation.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Evidence for nonvesicular nitric oxide release evoked by nerve activation.
@en
Evidence for nonvesicular nitric oxide release evoked by nerve activation.
@nl
type
label
Evidence for nonvesicular nitric oxide release evoked by nerve activation.
@en
Evidence for nonvesicular nitric oxide release evoked by nerve activation.
@nl
prefLabel
Evidence for nonvesicular nitric oxide release evoked by nerve activation.
@en
Evidence for nonvesicular nitric oxide release evoked by nerve activation.
@nl
P2093
P2860
P1476
Evidence for nonvesicular nitric oxide release evoked by nerve activation.
@en
P2093
L E Gustafsson
N P Wiklund
P2860
P304
P356
10.1046/J.1460-9568.2000.01021.X
P407
P577
2000-04-01T00:00:00Z